Impact Factor
4.93
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
12.44
19,663 total citations
h5-index
134
h5 depth signal
Cited share
87.8%
1,403 of 1,598
Total citations
19,663
Citation footprint
Metric signal
11.96
External metric anchor
Self-citation
4.7%
921 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
3,033
United States
1,694
South Korea
507
United Kingdom
359
Germany
314
Citing Fields of Research
Drug Delivery Systems
4,359
Polymer & Macromolecule Science
1,635
Immunology
1,341
Nanoparticles
1,145
Immunotherapy
639
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
18,491
Articles tracked across the journal lifetime
Indexed publication set
1,598
1,403 cited publications
Last 12 months
1,083
90.3 publications/month
Open access share
22.3%
241 OA publications in the last year
Leading citing country
China
3,033 citing publications
Leading citing field
Drug Delivery Systems
4,359 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v50n1-3,Jan. 2, 1998-
v50n1-3,Jan. 2, 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Immunology
Polymer & Macromolecule Science
Nanoparticles
Immunotherapy
Issuing & Sponsoring Bodies
Contributor
Controlled Release Society
Broad Categories
Pharmacology
Polymer & Macromolecule Science
Drug Delivery Systems
Immunology
Noncoding RNA
Nanoparticles
MeSH Descriptors
Delayed-Action Preparations
Dosage Forms
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jconrel.2026.115459
Open DOI
A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation
02
DOI 10.1016/j.jconrel.2026.115462
Open DOI
Nanomedicine strategies for overcoming cellular and microenvironmental barriers to cuproptosis-based cancer therapy
03
04
DOI 10.1016/j.jconrel.2026.115463
Open DOI
Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances
05
06
07
DOI 10.1016/j.jconrel.2026.115458
Open DOI
Hierarchically sequential targeting nanoplatform suppresses NETosis-promoted angiogenesis for corneal neovascularization therapy
08
DOI 10.1016/j.jconrel.2026.115448
Open DOI
Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments
09
10
DOI 10.1016/j.jconrel.2026.115456
Open DOI
Scalable cultured gut microbiota-derived nanovesicles for oral augmentation of checkpoint blockade therapy
Bibliographical & Catalog Notes
Title from caption.
Also available online.
(1989)19980811 Notice published Printed on acid-free paper